Bg pattern

ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information: Summary of Product Characteristics

Atolaxant 13.7 g powder for oral solution

macrogol 3350/sodium chloride/sodium hydrogen carbonate/potassium chloride

Read the entire patient information leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this patient information leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others,

even if they have the same symptoms as you, as it may harm them.

  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this patient information leaflet. See section 4.

Contents of the Patient Information Leaflet:

  1. What is Atolaxant and what is it used for
  2. What you need to know before taking Atolaxant
  3. How to take Atolaxant
  4. Possible side effects
  5. Storage of Atolaxant
  6. Package contents and additional information

1. What is Atolaxant and what is it used for

Atolaxant is a laxative used for the treatment of constipation (especially long-lasting constipation) in adults, adolescents, and elderly patients. It is not recommended for children under 12 years of age.

It is also used for the treatment of hard stools that have accumulated in the intestine as a result of long-lasting constipation (this is known as fecal impaction).

The active ingredient Macrogol 3350 softens the stools, making them pass more easily, relieving constipation. The electrolytes (salts) help maintain normal sodium, potassium, and water levels in your body while you are being treated for constipation.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Atolaxant

Do not take Atolaxant

  • if you are allergic to macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride, or any of the other ingredients of this medication (listed in section 6),
  • if you have a perforation in the intestinal wall,
  • if you have an intestinal blockage (intestinal obstruction, ileus),
  • if you have a severe inflammatory bowel disease, such as ulcerative colitis, Crohn's disease, or toxic megacolon.

Consult your doctor or pharmacist before taking this medication.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Atolaxant.

Before taking Atolaxant to treat symptoms of fecal impaction, your doctor must have confirmed that you have this condition.

If you have heart disease and are taking a product for fecal impaction, follow the special instructions indicated in section 3.

If you develop side effects such as swelling, difficulty breathing, fatigue, dehydration (symptoms including increased thirst, dry mouth, and weakness), or heart problems, you should stop taking Atolaxant and contact your doctor immediately.

If you experience sudden abdominal pain or rectal bleeding while taking Atolaxant for intestinal preparation, contact your doctor or go to a doctor immediately.

Children

It is not indicated for children under 12 years of age.

Other medications and Atolaxant

Tell your doctor or pharmacist if you are taking or have recently taken any other medication.

Some medications, such as antiepileptics, may not be as effective when administered with Atolaxant. Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

If you need to thicken fluids to swallow them safely, macrogol may counteract the effect of the thickener.

Pregnancy and breastfeeding

Atolaxant can be taken during pregnancy and breastfeeding.If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Driving and using machines

Atolaxant does not affect the ability to drive or use machines.

Atolaxant contains sodium, sorbitol, and potassium.

This medication contains 188 mg of sodium (main component of table salt/cooking salt) per sachet. This is equivalent to 9.4% of the maximum daily sodium intake recommended for an adult.

Consult your doctor or pharmacist if you need 3 or more sachets per day for an extended period, especially if you have been advised to follow a low-sodium diet.

The maximum daily dose of this medication in patients with chronic constipation contains 564 mg of sodium. This is equivalent to 28.2% of the maximum daily sodium intake recommended by the WHO.

Atolaxant has a high sodium content, which should be taken into account in patients with low-sodium diets.

The maximum daily dose of this medication in patients with fecal impaction contains 1504 mg of sodium. This is equivalent to 75.2% of the maximum daily sodium intake recommended by the WHO.

Consult your doctor or pharmacist if you need 3 or more sachets per day for an extended period, especially if you have been advised to follow a low-sodium diet.

Patients with renal insufficiency or low-potassium diets should note that this medication contains 24.4 mg (0.6 mmol) of potassium per sachet.

The lemon-lime flavoring of this medication contains 0.8 mg of sorbitol (E420) per sachet.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Atolaxant

Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

Constipation:

The dose of Atolaxant is one sachet dissolved in 125 ml (1/4 water). Take this 1 to 3 times a day, depending on the severity of your constipation.

Treatment with this medication usually lasts 2 weeks. If you need to take this medication for a longer period, consult your doctor. If your constipation is caused by a disease such as Parkinson's or multiple sclerosis (MS), or if you are taking medications that cause constipation, your doctor will recommend that you do not take this medication for more than 2 weeks. If you need to take this medication for a longer period, consult your doctor. Normally, for long-term treatment, the dose should be reduced to 1 or 2 sachets per day.

Fecal impaction

Before taking this medication for fecal impaction, it must be confirmed that you have this condition. A dose of 8 sachets per day of Atolaxant is needed for the treatment of fecal impaction. Each sachet should be dissolved in 125 ml (1/4 water) of water. The 8 sachets should be taken every 6 hours for 3 days if necessary. If you have heart disease, do not take more than 2 sachets in one hour.

Method of administration

Open the sachet and pour the contents into a glass. Add 125 ml of water or a quarter of water to the glass. Stir well until the powder is dissolved and the solution is clear or slightly cloudy, and then drink it.

If you are being treated for fecal impaction, you can dissolve the contents of eight sachets in a large container (in one liter of water).

This medication should be taken orally.

Children

Do not administer this medication to children under 12 years of age.

If you take more Atolaxant than you should

You may experience severe abdominal pain and inflammation (stomach) or vomiting (nausea) or diarrhea. Excessive diarrhea can lead to dehydration. If this occurs, stop taking this medication and drink plenty of fluids. If you experience these symptoms, consult your doctor or pharmacist.

If you have taken more Atolaxant than you should, consult your doctor, pharmacist, or call the Toxicology Information Service immediately, indicating the medication and the amount used.

If you forget to take Atolaxant

Take your dose as soon as you remember.

.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

If you experience any of the following side effects, stop taking Atolaxant and go to your doctor immediately:

  • Signs of allergy such as eczema, itching, redness of the skin, shortness of breath or difficulty breathing, or swelling of the face, lips, tongue, or throat.
  • Signs of changes in your body's fluids or electrolyte levels, such as swelling (mainly in the ankles), weakness, dehydration, increased fatigue, or increased thirst with headache. These symptoms may be a sign that your potassium levels are higher or lower than normal.

Other side effects include:

  • swelling of hands, feet, and ankles,
  • headache,
  • indigestion, stomach pain, cramps,
  • feeling bloated, belching, feeling nauseous or vomiting,
  • anal pain (anus),
  • diarrhea (when starting to take this medication),
  • changes in your body's fluid or electrolyte levels (low sodium levels).

These side effects usually improve if you reduce the amount of Atolaxant you take.

The frequency of these side effects is not known (cannot be estimated from available data).

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this patient information leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Atolaxant

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the packaging and sachet after CAD/EXP. The expiration date is the last day of the month indicated.

Do not store above 25°C.

Once Atolaxant is reconstituted in water, keep it covered and store it in the refrigerator (between 2°C and 8°C), and it must be taken within 24 hours. After 24 hours, any remaining reconstituted solution should be discarded.

Do not use this medication if you notice any signs of deterioration in the sachet.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Atolaxant

  • The active ingredients are:

Each sachet contains:

macrogol 3350 13.125 g

sodium chloride 0.3507 g

sodium hydrogen carbonate 0.1785 g

potassium chloride 0.0466 g

The other ingredients (excipients) are: colloidal anhydrous silica, sodium saccharin, orange flavoring (the orange flavoring contains: flavoring substances and flavoring preparations, maltodextrin, gum arabic (E 414), and alpha-tocopherol (E 307)), and lemon-lime flavoring (the lemon-lime flavoring contains: natural lemon oil, natural lemon powder, lime powder, maltodextrin, mannitol (E 421), gluconolactone (E 575), sorbitol (E 420), gum arabic (E 414), and colloidal anhydrous silica (E 551))

Appearance of the product and package contents

Atolaxant is a white crystalline powder.

The sachet is composed of PAP/ALU/PE.

Each sachet contains 13.7 g of powder for oral solution and is presented in cardboard boxes containing 2, 6, 8, 10, 20, 30, 50, 60 (2x30), and 100 (2x50) sachets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Sandoz Farmacéutica, S.A.

Centro Empresarial Parque Norte

Edificio Roble

C/ Serrano Galvache, 56

28033 Madrid

Spain

Manufacturer

Klocke Pharma-Service GmbH

Strassburger Strasse 77,

77767 Appenweier

Germany

or

Salutas Pharma GmbH

Otto-von-Guericke-Allee 1, 39179 Barleben

Germany

or

Hermes Pharma Ges.m.b.H.

Schwimmschulweg 1a

9400 Wolfsberg

Austria

This medication is authorized in the Member States of the European Economic Area under the following names:

Germany Macrogol Hexal plus Elektrolyte Pulver zur Herstellung einer Lösung zum Einnehmen

Austria Laxoglam-Pulver zur Herstellung einer Lösung zum Einnehmen

Belgium Macrogol+electrolytes Sandoz poeder voor drank

Denmark Gangiden

Netherlands Macrogol en elektrolyten Sandoz 13,8 g poeder voor drank

Ireland Macrolief 13.125g + 351mg + 179mg + 47mg sachet, powder for oral solution

Italy MACROGOL SANDOZ 13.125 g + 351 mg + 179 mg + 47 mg polvere per soluzione orale

Luxembourg Macrogol+electrolytes Sandoz poudre pour solution buvable

Sweden Laxiriva pulver till oral lösning, i dospåse

United Kingdom Compound Macrogol 13.8g Powder for Oral Solution

Malta Macrolief 13.8g sachet, powder for oral solution

Date of the last revision of this patient information leaflet:February 2022

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION

Discuss questions about ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION?
ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION?
The active ingredient in ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION is macrogol, combinations. This information helps identify medicines with the same composition but different brand names.
Who manufactures ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION?
ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION is manufactured by Sandoz Farmaceutica S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ATOLAXANT 13.7 g POWDER FOR ORAL SOLUTION?
Other medicines with the same active substance (macrogol, combinations) include ACOLORA POWDER FOR ORAL SOLUTION IN SACHET, BIMOTIL 13.7 g POWDER FOR ORAL SOLUTION, BIMOTIL INFANTIL 6.9 g ORAL SOLUTION POWDER. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media